Skip to content
healthcare.dev

EPIVIR

NDC 49702-205, lamivudine, solution, from ViiV Healthcare Company.

Product NDC
49702-205
Status
Listed
Labeler
ViiV Healthcare Company
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020596
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49702-205 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE10 mg/mL

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
49702-205-4849702020548240 mL in 1 BOTTLE (49702-205-48)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89226149-47fa-4f7d-bb1f-1aa7034486b8

Use it

Look up 49702-205 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49702-205 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49702-205. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.